Hangping Ge

5PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersChemotherapyCardiovascular medicine and haematology not elsewhere classifiedAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 26, 2026
Favorable response to second-line sirolimus regardless of STAT3/5b status in acquired pure red cell aplasia: A retrospective study from a single center.

|Sep 09, 2024
Ferroptosis-Related Gene Signature for Prognosis Prediction in Acute Myeloid Leukemia and Potential Therapeutic Options.

Yaonan Hong, Qi Liu, Chuanao Xin

|Mar 08, 2024
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for Bruton's tyrosine kinase inhibitors (BTKis) single and its combination therapy.

Sichun Xiang, Rongbin Shen, Jingjing Xiang

|Mar 30, 2022
Coexistence of thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in an Asian woman: a case report.

Hangping Ge, Zhan Shi, Zhiyin Zheng

|Oct 22, 2021
First Report of Severe Autoimmune Hemolytic Anemia During Eltrombopag Therapy in Waldenström Macroglobulinemia-Associated Thrombocytopenia.

Yingying Shen, Fanhua Yu, Hangping Ge

Pageof 1

Frequent Collaborators

3 joint publications

Dijiong Wu

2 joint publications

Baodong Ye

2 joint publications

Yingying Shen

1 joint publications

Shu Deng